PharmaVOICE - 
Nov./Dec. 2008
Purchase Issue

In Every Issue
Talent Pool
Pharma POOL Dr. Barry Goldstein Merck Appoints Head of Diabetes, [...]
By
E-Media
NEW ELECTRONIC AND WEB BASED APPLICATIONS, SITES, AND TECHNOLOGIES The [...]
By
What’s New
NEW HEALTHCARE RELATED PRODUCTS, SERVICES, AND COMPANIES The American Heart [...]
By
UpFront
CONSUMER PERSPECTIVE Consumers Wary of Therapeutic Switches Almost three quarters [...]
By
Letter from the Editor
Pharmaceutical companies as well as their partners are feeling the [...]
By

Taren Grom, Editor

On The Cover

An Industry Overview
The industry started feeling the pinch of belt-tightening almost a decade ago, slowly at first. But today’s pressures must feel like a vise grip. Being squeezed from all sides, life-sciences companies are having to counter multiple challenges of tremendous magnitude: increased regulatory scrutiny, the need to control costs, generic competition, pricing pressures, and reputation management, [...]
By

Robin Robinson And Denise Myshko

Features

Doctors’ Choice Awards
Identifying POWERful MEDICAL ADVERTISING 6th Annual Program Generated Responses From More Than 5,700 Physicians Dusa’s ClindaReach and Pfizer’s Chantix Highest Scoring Ads ClindaReach Category: Highest-Scoring Ad (Specialist Audience) Marketer: Dusa Agency: Topin & Associates Chantix Category: Highest-Scoring Ad (Generalist Audience) Marketer: Pfizer Agency: Euro RSCG Life LM&P Colazal Category: Highest-Scoring Ad (One Page) Marketer: Salix [...]
By
Patient Education
Communication Strategies PATIENT EDUCATION Old School Communications With a twist As the techno-wave continues to roll over and roll up into marketing plans, product managers still need to reach patients with branded and nonbranded educational messages that resonate on a personal level and connect them with their physicians. BY TAREN GROM Patient education is at [...]
By

Taren Grom, Editor

Marketing
SALES & Marketing MARKETING Web 2.0 Marketing in 2009 AND BEYOND Pharma begins the move from informing to interacting and embracing the Web 2.0 revolution and emerging media options. BY Robin Robinson The industry has been using the Internet to inform and educate consumers for several years. Few companies, however, have taken the next step [...]
By

Robin Robinson

Salesforces
SALES & Marketing Salesforces The Salesforce of the Future: MORE SERVICE, LESS SELL As companies — Sanofi-Aventis, Merck, Wyeth, Schering-Plough, Novartis — continue to make headlines for collectively laying off thousands of sales representatives, the industry looks for innovative ways to do more with less, and in the coming years, that means adding a value [...]
By

Robin Robinson

Patient Recruitment
RESEARCH & Development BY DENISE MYSHKO Patient Recruitment The Continuing Saga of Patient-Recruitment Bottlenecks If patient recruitment wasn’t already hard enough, larger, more complex trials have made the enrollment of patients even more challenging. Clinical-trial patient recruitment and retention continue to be widely recognized as some of the leading challenges in drug development. Almost half [...]
By

Denise Myshko

Personalized Medicine
RESEARCH & Development PERSONALIZED MEDICINE The Right Dose at the Right time BY DENISE MYSHKO Obstacles and challenges still remain to make the vision of personalized medicine a reality. Despite some early successes, the development of targeted medicines and pharmacogenomics-based testing has been slower than anticipated. The shift to developing personalized medicines is going to mean [...]
By

Denise Myshko

Development
development RESEARCH & Development BY DENISE MYSHKO Models of CHANGE In the future, successful biopharmaceutical companies will be those that have reviewed R&D business models and implemented updated strategies for improving the development of new products. The pharmaceutical industry is at a critical point in its evolution. The needs of patients are changing, regulators are [...]
By

Denise Myshko

Early Research
RESEARCH & Development Early Research The Future of innovation Discovery and research technologies are advancing and will have a tremendous impact on the pipelines of the future. BY DENISE MYSHKO The way new medicines are discovered is on the cusp of revolutionary change. Advances in the understanding of the body at the molecular level and of [...]
By

Denise Myshko

Counterfeit Drugs
Corporate Strategy Counterfeit Drugs Fighting an uphill battle BY DENISE MYSHKO The counterfeit medicines market is a real, clear, and present danger to public health. And while there have been efforts to minimize the threat of counterfeit and substandard medicines, there is a need to coordinate the efforts of all the various public and private [...]
By

Denise Myshko

Globalization
Corporate Strategy GLOBALIZATION BY TAREN GROM Risks and Rewards The global landscape is changing. Countries once thought of as secondary or tertiary markets are providing opportunities for not only pharmaceutical companies but for their contract research and marketing partners as well. IMS’s 2009 Pharmaceutical Market Forecast reports that growth rates will level out and hold [...]
By

Taren Grom, Editor

The Corner Office
Corporate Strategy A review of the annual reports and public statements of more than two dozen of the industry’s publicly traded pharmaceutical/biotechnology companies reveals the top trends as identified by the CEOs, presidents, and executive management teams of these industry standard bearers. (Editor’s Note: Predictions are presented in alphabetical order by contributor’s company.) Thinking Outside [...]
By
Crystal Ball
LOOKING Forward The CRYSTAL BALL We asked our readers to act as prognosticators and identify the top trends that they expect to shape the industry in the coming year and beyond. Some of their responses may already be part of your strategic vision, while others may add a wrinkle to your plans. Whether you agree [...]
By
At A Glance
Looking Forward At a GLANCE This special Year in Preview issue provides insights into the trends that will impact the industry in the coming year and beyond. Below are some highlights from the sectors covered in the following pages. Focus on specialty markets David Avitabile President JFK Communications Inc. Last year, I predicted that during [...]
By
FEEDBACK